CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a U.S. National Stage entry under 35 U.S.C. .sctn.371 of International Application No. PCT/CN2012/077030, filed on Jun. 15, 2012, designating the United States of America and published in Chinese on Aug. 29, 2013, which in turn
This application is a 371 of PCT/JP95/01680, filed Aug. 24, 1995.
TECHNICAL FIELD
This invention relates to an (R)-3,6-diamino-N-(.omega.-aminoalkyl)hexanamide which is a novel compound active for inhibiting the growth of Gram-positive bacteria and Gram-negative bacteria, the infection of human